Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Biggioggero

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Rheumatology Reports|September 21, 2001
OsteoporosisR Cimaz, M Biggioggero
Scandinavian Journal of Rheumatology|July 29, 2020
Is there really room for anti-rheumatic drugs in the treatment of COVID-19?E G Favalli, F Ingegnoli, M Biggioggero, et al.
Lupus|June 5, 2002
Ultraviolet light exposure is not a requirement for the development of cutaneous neonatal lupusR Cimaz, M Biggioggero, L Catelli, et al.
Minerva Pediatrica|September 21, 2005
[Arthritis and infections]R Cimaz, E Meregalli, M Biggioggero, et al.
Autoimmunity Reviews|September 25, 2010
Updating on the pathogenesis of systemic lupus erythematosusR Gualtierotti, M Biggioggero, A E Penatti, et al.
Rheumatology (Oxford, England)|February 6, 2008
Comment on: Bisphosphonates and osteonecrosis of the jawM L Bianchi, C Limonta, J Frasunkiewicz, et al.
Lupus|August 23, 2007
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressantsM Biggioggero, M O Borghi, M Gerosa, et al.
Toxicology Letters|April 20, 2004
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancyR Cimaz, E Meregalli, M Biggioggero, et al.
Lupus|April 4, 2007
Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disordersR Cimaz, E Meregalli, M Biggioggero, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Rheumatology Reports|September 21, 2001
OsteoporosisR Cimaz, M Biggioggero
Scandinavian Journal of Rheumatology|July 29, 2020
Is there really room for anti-rheumatic drugs in the treatment of COVID-19?E G Favalli, F Ingegnoli, M Biggioggero, et al.
Lupus|June 5, 2002
Ultraviolet light exposure is not a requirement for the development of cutaneous neonatal lupusR Cimaz, M Biggioggero, L Catelli, et al.
Minerva Pediatrica|September 21, 2005
[Arthritis and infections]R Cimaz, E Meregalli, M Biggioggero, et al.
Autoimmunity Reviews|September 25, 2010
Updating on the pathogenesis of systemic lupus erythematosusR Gualtierotti, M Biggioggero, A E Penatti, et al.
Rheumatology (Oxford, England)|February 6, 2008
Comment on: Bisphosphonates and osteonecrosis of the jawM L Bianchi, C Limonta, J Frasunkiewicz, et al.
Lupus|August 23, 2007
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressantsM Biggioggero, M O Borghi, M Gerosa, et al.
Toxicology Letters|April 20, 2004
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancyR Cimaz, E Meregalli, M Biggioggero, et al.
Lupus|April 4, 2007
Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disordersR Cimaz, E Meregalli, M Biggioggero, et al.
Pageof 1